Alimera Sciences (NASDAQ:ALIM) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a report released on Saturday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Other equities analysts also recently issued research reports about the stock. Craig Hallum cut their price objective on shares of Alimera Sciences from $18.00 to […]

Related Keywords

Craig Hallum ,Alimera Sciences Company Profile ,Susquehanna International Group ,Alimera Sciences ,Nasdaq ,Renaissance Technologies ,News Ratings For Alimera Sciences Daily ,Alimera Sciences Inc ,Securities Exchange Commission ,Alimera Sciences Trading ,Millennium Management ,Get Rating ,Alto Investors Lp Palo ,Exchange Commission ,International Group ,Alimera Sciences Daily ,Nasdaq Alim ,Bsalim ,Medical ,Initiated Coverage ,Stocknews Com ,